Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
danoprevir (ITMN-191, RG7227) (formerly R7227)
Also known as: formerly ITMN B
print preview
bookmark
share with colleague
General Information
Company
Roche
Description
HCV NS3/4A protease inhibitor
Molecular Target
HCV NS3/4A protease complex
Mechanism of Action
Viral protease inhibitor
Latest Stage of Development
Phase II/III
Indication
Hepatitis C virus (HCV)
Partner
Ascletis Pharmaceuticals Co. Ltd.
;
Roche
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy